Abstract:Abstract CRSIPR-Cas9 system has opened up the avenue to efficient genome editing 1–4 . However, together with known off-target effects, several concerns of current CRISPR-Cas9 platform, including severe DNA damage, cytotoxicity, and large genomic alteration, have emerged in recent reports 5–7 and establish a formidable obstacle to precisely model allele dosage effects of disease mutations and risk variants, especially mono-allelic effects, and correct them. Here, by developing an allele-specific indel monitor system (AIMS), we demonstrate that small and simple modification of conventional single-guide RNAs (sgRNAs) enable programmable tuning of CRISPR-Cas9 activities and alleviate such adverse effects. AIMS, which visualizes various indel events in two alleles separately in living cells, is convenient and accurate to determine the in vitro editing efficiency and revealed frequent mosaicism during genome editing. Using AIMS, we show that adding cytosine stretches to the 5’ end of conventional sgRNA efficiently reduced Cas9 activity in a length dependent manner. By combining systematic experiments and computational modeling, we established the quantitative relationships between the length of cytosine extension and multiple aspects of CRISPR-Cas9 system. In general, short cytosine extension dramatically relieves p53-dependent cytotoxicity and suppression of homology-directed repair (HDR) while relatively maintaining on-target activity. Long cytosine extension further decreases on-target activity, thereby maximizing mono-allelic editing, while conventional system typically induces bi-allelic editing. Furthermore, such downregulation of on-target activity contributes to downregulation of relative off-target activity and protection of HDR-allele from second off-target editing. Therefore, cytosine extension method finally enables both single-step generation of heterozygous single-nucleotide disease mutations from homozygous states in mouse ES cells and correction of heterozygous disease mutations in human iPS cells. Taken together, our study proposes updates of standard CRISPR-Cas9 platform in mammalian cells toward precise and safe genome editing in diverse applications.

One-step homozygosity in precise gene editing by an improved CRISPR/Cas9 system

High-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention by improving specificity of the tools

Shortened Snrna Promoters for Efficient CRISPR/Cas-based Multiplex Genome Editing in Monocot Plants

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Recent Progress in CRISPR/Cas9 Technology

The application of CRISPR /Cas mediated gene editing in synthetic biology: Challenges and optimizations

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering

Strategies for High-Efficiency Mutation Using the CRISPR/Cas System

Improving the Efficiency of Precise Genome Editing with Site-Specific Cas9-oligonucleotide Conjugates

Programmable downsizing of CRISPR-Cas9 activity for precise and safe genome editing

Harnessing noncanonical crRNA for highly efficient genome editing

Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Chemical Modification and Transformation Strategies of Guide RNAs in CRISPR‐Cas9 Gene Editing Systems

Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates

Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase

CRISPR/Cas9-assisted gRNA-free one-step genome editing with no sequence limitations and improved targeting efficiency

Screening DNA Aptamers That Control the DNA Cleavage, Homology-Directed Repair, and Transcriptional Regulation of the CRISPR-(d)Cas9 System.